APA is currently working with the American Telemedicine Association to urge the Department of Justice and the Drug Enforcement Agency (DEA) to promulgate regulations to offer prescribing clinicians a long-term solution to this issue and to provide short-term guidance and continued flexibility when the Public Health Emergency ends to ensure patients have continued access to care.
Unfortunately, the APA is at the mercy of the DEA’s action / non-action and because they know members are anxious about the potential mid-January deadline, they will be hosting a webinar in the coming weeks. Registration information will be shared once it becomes available.
Earlier this year, several organizations focused on health care access and public health sent a letter to strongly encourage the DEA to collaborate with the Department of Health and Human Services (HHS) to consider public health and health care access during the development of the Special Registration process for the use of telemedicine to prescribe controlled substances under the Ryan Haight Act. You may view the letter here.
Worth a Read
April 12, 2024
